Cargando…

Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy

Detalles Bibliográficos
Autores principales: Xu, Zhikun, Zhang, Xiaozhan, Dong, Wang, lv, Huifang, Zuo, Lijie, Zhu, Lifei, Wang, Ruining, Ma, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325822/
https://www.ncbi.nlm.nih.gov/pubmed/37426422
http://dx.doi.org/10.3389/fmolb.2023.1232803
_version_ 1785069297879482368
author Xu, Zhikun
Zhang, Xiaozhan
Dong, Wang
lv, Huifang
Zuo, Lijie
Zhu, Lifei
Wang, Ruining
Ma, Xia
author_facet Xu, Zhikun
Zhang, Xiaozhan
Dong, Wang
lv, Huifang
Zuo, Lijie
Zhu, Lifei
Wang, Ruining
Ma, Xia
author_sort Xu, Zhikun
collection PubMed
description
format Online
Article
Text
id pubmed-10325822
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103258222023-07-07 Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy Xu, Zhikun Zhang, Xiaozhan Dong, Wang lv, Huifang Zuo, Lijie Zhu, Lifei Wang, Ruining Ma, Xia Front Mol Biosci Molecular Biosciences Frontiers Media S.A. 2023-06-22 /pmc/articles/PMC10325822/ /pubmed/37426422 http://dx.doi.org/10.3389/fmolb.2023.1232803 Text en Copyright © 2023 Xu, Zhang, Dong, lv, Zuo, Zhu, Wang and Ma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Xu, Zhikun
Zhang, Xiaozhan
Dong, Wang
lv, Huifang
Zuo, Lijie
Zhu, Lifei
Wang, Ruining
Ma, Xia
Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy
title Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy
title_full Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy
title_fullStr Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy
title_full_unstemmed Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy
title_short Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy
title_sort corrigendum: self-assembling and ph-responsive protein nanoparticle as potential platform for targeted tumor therapy
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325822/
https://www.ncbi.nlm.nih.gov/pubmed/37426422
http://dx.doi.org/10.3389/fmolb.2023.1232803
work_keys_str_mv AT xuzhikun corrigendumselfassemblingandphresponsiveproteinnanoparticleaspotentialplatformfortargetedtumortherapy
AT zhangxiaozhan corrigendumselfassemblingandphresponsiveproteinnanoparticleaspotentialplatformfortargetedtumortherapy
AT dongwang corrigendumselfassemblingandphresponsiveproteinnanoparticleaspotentialplatformfortargetedtumortherapy
AT lvhuifang corrigendumselfassemblingandphresponsiveproteinnanoparticleaspotentialplatformfortargetedtumortherapy
AT zuolijie corrigendumselfassemblingandphresponsiveproteinnanoparticleaspotentialplatformfortargetedtumortherapy
AT zhulifei corrigendumselfassemblingandphresponsiveproteinnanoparticleaspotentialplatformfortargetedtumortherapy
AT wangruining corrigendumselfassemblingandphresponsiveproteinnanoparticleaspotentialplatformfortargetedtumortherapy
AT maxia corrigendumselfassemblingandphresponsiveproteinnanoparticleaspotentialplatformfortargetedtumortherapy